In a first ever head-to-head biologic clinical study in Ulcerative Colitis Takeda's Entyvio demonstrates superior results compared to Humira

Takeda Pharmaceutical Company Limited has announced results from the Phase 3b head-to-head VARSITY study which demonstra...

March 11, 2019 | Monday | News
P&P biotech obtains US patent for its platform technology

China-based high-tech firm P&P Biotech has been awarded a patent from the US for its hydrophilic, electro-...

March 11, 2019 | Monday | News
Trinity Biotech announces Q4 and FY 2018 financial results

Trinity Biotech plc, a leading developer and manufacturer of diagnostic products for the point-of-care and clinical labo...

March 8, 2019 | Friday | News
SOM Biotech closes a financing round of 7M Euros

SOM Biotech, a clinical-stage drug discovery and development company focused on repurposing drugs for orphan diseases of...

March 8, 2019 | Friday | News
FDA accepts Genentech's XOFLUZA for the treatment of Influenza

Genentech, a member of the Roche Group has announced that the U.S. Food and Drug Administration (FDA) has accepted a sup...

March 6, 2019 | Wednesday | News
Procarta raises €1.5M funding to develop new antibiotics

Procarta Biosystems, a biotech company has announced €1.5 million of new funding from the Novo Holdings REPAIR Impa...

March 5, 2019 | Tuesday | News
Pressure BioSciences collaborates with The Steinbeis Centre

Pressure BioSciences has announced a collaboration with The Steinbeis Centre for Biopolymer Analysis & Biomedical Ma...

March 5, 2019 | Tuesday | News
3SBio, TLC to commercialize two NanoX products in Mainland China

3SBio Inc. and Taiwan Liposome Company, Ltd. (TLC) have announced an exclusive partnership to commercialize in mainland ...

March 4, 2019 | Monday | News
Israel Innovation Authority approves NIS 13.6M for Kadimastem

An Israeli biotechnology company Kadimastem announces that it has received approval for its annual budget from the Israe...

March 4, 2019 | Monday | News
Kadimastem completes cell transplantation of AstroRx in ALS patients

Israeli biotechnology company Kadimastem has announced the completion of cell transplantation (AstroRx®) in 5 patien...

March 1, 2019 | Friday | News
Rakuten Aspyrian changes name to Rakuten Medical

Rakuten Aspyrian, a biotechnology company developing precision-targeted cancer therapies based on its proprietary Photoi...

March 1, 2019 | Friday | News
Abpro, NJCTTQ to develop multiple novel bispecific antibodies

Abpro, a biotechnology company dedicated to developing next-generation antibody therapeutics to improve the lives of pat...

March 1, 2019 | Friday | News
Amicus begins global research and gene therapy centre of excellence

Amicus Therapeutics is establishing a new Global Research and Gene Therapy centre of Excellence in&n...

February 28, 2019 | Thursday | News
Axial Biotherapeutics raises $25M in series b financing

Axial Biotherapeutics, a biotechnology company building a unique class of gut-targeted programs for neurodegenerative an...

February 28, 2019 | Thursday | News
Innovent bags two International Finance Review Awards

Innovent Biologics announced that it has received the International Finance Review (IFR) Asia-Pacific IPO of the Year 20...

February 27, 2019 | Wednesday | News
India needs good innovation policy: Talk-point at CEO conclave in BioAsia 2019

At the ongoing 16th edition of BioAsia 2019, an exclusive conclave with the CEOs of top pharma companies was conducted. ...

February 26, 2019 | Tuesday | News
Gain Therapeutics SA announces funding support from a leading Parkinson's Research Foundation

Gain Therapeutics SA, a biotechnology company discovering and developing novel therapeutics to target lysosomal enzymes ...

February 26, 2019 | Tuesday | News
Marinomed receives EUR 15M EIB financing

The European Investment Bank (EIB) is providing EUR 15 million to Marinomed Biotech AG, a Vienna- based Biopharmaceutica...

February 26, 2019 | Tuesday | News
Can-Fite expands its Namodenoson Distribution Deal with CKD

Can-Fite BioPharma, a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer...

February 27, 2019 | Wednesday | News
Gracell raises $85M in series B funding

Gracell Biotechnologies is an innovative biomedical company focusing on the development of new generation low-cost, cell...

February 26, 2019 | Tuesday | News
ABL Bio, WuXi Bio expand strategic collaboration for $220M

WuXi Biologics a leading global open-access biologics technology platform company offering end-to-end solutions for biol...

February 26, 2019 | Tuesday | News
BioAsia 2019 rings in Telangana Life Sciences Grid

With the intent to strengthen a robust ecosystem for Lifesciences, Biotech, Healthcare enterprises, Telangana State Gove...

February 25, 2019 | Monday | News
AbbVie and Voyager Therapeutics announce collaboration

AbbVie, biopharmaceutical company and Voyager Therapeutics, a clinical-stage gene therapy company focused on developing ...

February 25, 2019 | Monday | News
BiomX raises $32M in Series B Financing

BiomX Ltd., a microbiome company developing customized phage therapies has announced the closing of a $32 million series...

February 25, 2019 | Monday | News
Generex Biotechnology Subsidiary granted approval for ECM hydrogel

Generex Biotechnology has announced that the company’s subsidiary Regentys Corporation, a clinical stage regenerat...

February 21, 2019 | Thursday | News